Literature DB >> 6321850

[Reproducibility of acute captopril-induced renal insufficiency with enalapril].

W Cremer.   

Abstract

In this case we are reporting on a patient suffering from malignant renovascular hypertension and chronic renal failure due to occlusion of both renal arteries. The acute renal insufficiency after Captopril and later on after Enalapril treatment was fully reversible. We believe that the acute reversible renal insufficiency was caused by the blockage of glomerular autoregulation depending on Angiotensin II.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6321850     DOI: 10.1007/bf01725192

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  23 in total

1.  Reversible renal failure during treatment with captopril.

Authors:  P R Farrow; R Wilkinson
Journal:  Br Med J       Date:  1979-06-23

2.  Reversible renal failure during treatment with captopril.

Authors:  P Collste; K Haglund; G Lundgren; G Magnusson; J Ostman
Journal:  Br Med J       Date:  1979-09-08

3.  Captopril: reversible renal failure with severe hyperkalaemia.

Authors:  A Grossman; D Eckland; P Price; C R Edwards
Journal:  Lancet       Date:  1980-03-29       Impact factor: 79.321

4.  Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension.

Authors:  J J Curtis; R G Luke; J D Whelchel; A G Diethelm; P Jones; H P Dustan
Journal:  N Engl J Med       Date:  1983-02-17       Impact factor: 91.245

5.  Captopril and renal autoregulation.

Authors:  W B Blythe
Journal:  N Engl J Med       Date:  1983-02-17       Impact factor: 91.245

6.  Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney.

Authors:  D E Hricik; P J Browning; R Kopelman; W E Goorno; N E Madias; V J Dzau
Journal:  N Engl J Med       Date:  1983-02-17       Impact factor: 91.245

7.  [Progressive reversible kidney insufficiency after blood pressure reduction with captopril].

Authors:  J Kindler; A Konrads; K A Meurer; H G Sieberth
Journal:  Internist (Berl)       Date:  1981-06       Impact factor: 0.743

8.  Symposium on angiotensin-converting enzyme inhibition: a developing concept.

Authors: 
Journal:  Am J Cardiol       Date:  1982-04-21       Impact factor: 2.778

9.  Effect of exogenous and endogenous angiotensin II in the isolated perfused rat kidney.

Authors:  M Dávalos; N S Frega; B Saker; A Leaf
Journal:  Am J Physiol       Date:  1978-12

10.  Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorothiazide.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

View more
  2 in total

Review 1.  Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  P A Todd; R C Heel
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

2.  Tolerability of long term therapy with enalapril maleate in patients resistant to other therapies and intolerant to captopril.

Authors:  E J Rucinska; R Small; W S Mulcahy; D L Snyder; P V Rodel; J E Rush; R D Smith; J F Walker; J D Irvin
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.